Larson Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Larson Financial Group’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$24	Buy
2024 Q4	–	Sell
2024 Q3	$1.36K	Sell
2024 Q2	$2.31K	Buy
2024 Q1	$1.09K	Buy